Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EJENDOMSVIRKSOMHEDEN SKEJBY PRIVATHOSPITAL ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 6.0% 6.0%   Bankruptcy risk   0.6% 2.4% 1.2% 0.8% 0.9% 3.0% 11.1% 10.9%   Credit score (0-100)   97 64 81 90 90 52 22 22   Credit rating   AA BBB A AA A BBB BB BB   Credit limit (kDKK)   1,418.6 0.1 239.6 1,085.9 1,181.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,365 1,905 2,068 1,723 165 1,538 0.0 0.0   EBITDA   2,365 1,905 2,068 1,723 165 1,538 0.0 0.0   EBIT   2,306 1,848 2,010 1,666 105 1,476 0.0 0.0   Pre-tax profit (PTP)   2,003.8 -2,069.8 -1,031.5 2,156.7 3,652.3 -2,595.0 0.0 0.0   Net earnings   1,532.4 -2,370.1 -924.6 1,835.0 3,451.2 -2,798.4 0.0 0.0   Pre-tax profit without non-rec. items   2,004 -2,070 -1,032 2,157 3,652 -2,595 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   17,588 17,531 17,474 17,417 17,403 17,342 0.0 0.0   Shareholders equity total   13,436 11,065 10,141 11,976 15,427 12,629 12,329 12,329   Interest-bearing liabilities   13,559 15,204 15,464 15,081 15,443 15,154 0.0 0.0   Balance sheet total (assets)   28,005 27,281 26,327 27,682 31,950 28,957 12,329 12,329   Net Debt   13,559 15,204 15,464 14,572 15,443 15,154 -12,329 -12,329     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,365 1,905 2,068 1,723 165 1,538 0.0 0.0   Gross profit growth   -82.6% -19.5% 8.5% -16.7% -90.4% 833.0% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   28,005 27,281 26,327 27,682 31,950 28,957 12,329 12,329   Balance sheet change%   -8.6% -2.6% -3.5% 5.1% 15.4% -9.4% -57.4% 0.0%   Added value   2,365.2 1,904.9 2,067.5 1,723.1 162.5 1,538.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -119 -114 -114 -114 -73 -124 -17,342 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   97.5% 97.0% 97.2% 96.7% 63.9% 96.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.6% -5.7% 5.5% 9.8% 13.9% -6.7% 0.0% 0.0%   ROI %   9.3% -5.8% 5.6% 9.9% 14.0% -6.9% 0.0% 0.0%   ROE %   12.1% -19.3% -8.7% 16.6% 25.2% -19.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   48.0% 40.6% 38.5% 43.3% 48.3% 43.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   573.3% 798.2% 748.0% 845.7% 9,368.0% 985.3% 0.0% 0.0%   Gearing %   100.9% 137.4% 152.5% 125.9% 100.1% 120.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 3.5% 16.4% 3.2% 3.2% 3.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.6 0.7 0.8 0.5 0.5 0.0 0.0   Current Ratio   0.4 0.6 0.7 0.8 0.5 0.5 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 508.9 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,355.0 -2,669.4 -2,666.6 -1,817.2 -4,698.7 -4,364.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0